Hepatitis

Hepatitis Overview

  • Definition: Hepatitis is the inflammation of the liver, which can be caused by various factors, leading to liver cell damage and impaired function.

  • Causes:

    • Viruses (most common cause)

    • Bacteria (less common)

    • Exposure to medication or hepatotoxic agents (e.g., alcohol, certain chemicals, or drugs)

    • Autoimmune conditions where the body's immune system attacks liver cells

Types of Hepatitis

  • Acute Hepatitis:

    • Characterized by sudden onset and lasts for 6 months or less.

    • Most cases resolve completely, but some can progress to chronic or, rarely, fulminant liver failure.

  • Chronic Hepatitis: Persists for longer than 6 months; it can be lifelong and often leads to progressive liver damage, fibrosis, and potentially cirrhosis or liver cancer if untreated.

  • Stages:

    • Preicteric (prodromal): The initial stage before jaundice appears, characterized by vague, flu-like symptoms.

    • Icteric: Marked by the appearance of jaundice (yellowing of skin and eyes due to elevated bilirubin) along with its associated symptoms like dark urine, clay-colored stools, and intense itching.

    • Posticteric: The convalescent stage, occurring after the acute symptoms, including jaundice, have subsided, and the liver inflammation begins to resolve.

Causes and Types of Hepatitis

  • Inflammation and Necrosis: Hepatitis involves both inflammation (swelling of liver tissue) and necrosis (death of liver cells), which can impair the liver's critical functions such as detoxification, protein synthesis, and bile production.

  • Five Main Types of Viral Hepatitis:

    • Hepatitis A (HAV):

      • Transmitted primarily via the fecal-oral route, typically through contaminated food or water.

      • It causes an acute illness and does not lead to chronic infection.

    • Hepatitis B (HBV):

      • Transmitted via blood, semen, and other body fluids.

      • It can cause both acute and chronic infection and is a major global health problem due to its potential for leading to cirrhosis and liver cancer.

    • Hepatitis C (HCV):

      • Primarily spread through blood-to-blood contact (e.g., IV drug use, contaminated medical equipment).

      • Often asymptomatic for years, it frequently leads to chronic infection, significantly increasing the risk of cirrhosis and liver cancer.

    • Hepatitis D (HDV or ā€œdelta hepatitisā€):

      • A 'dependent' virus that can only replicate in the presence of Hepatitis B virus (HBV).

      • Co-infection with HBV and HDV often results in a more severe form of hepatitis.

    • Hepatitis E (HEV):

      • Transmitted through tainted meat or fecally contaminated water, especially prevalent in areas with poor sanitation.

      • It usually causes an acute, self-limiting illness but can be severe in pregnant women or individuals with pre-existing liver disease.

    • Hepatitis F:

      • A term historically used for acute hepatitis not attributed to types A-E and not caused by drugs or autoimmune diseases; it is not widely recognized as a distinct viral hepatitis type.

    • Hepatitis G (HGV):

      • Also known as GBV-C, it is most commonly detected as a co-infection with Hep B or C or HIV.

      • Its clinical significance and pathogenic role are still under investigation.

Viral Hepatitis

  • Transmission Routes:

    • Infectious blood or blood products (e.g., transfusions, needle sharing)

    • Sharing personal items contaminated with the virus (e.g., razors, toothbrushes)

    • Perinatal (vertical) transmission (from mother to newborn during birth)

    • Various sexual activities, especially unprotected sexual contact

Classification and Causes of Hepatitis

Acute Hepatitis ā€“ Causes

  • Viral Causes:

    • HAV, HBV, HCV, HDV, HEV

    • Other viruses: Herpes Simplex, Cytomegalovirus (CMV), Epstein-Barr virus (EBV), Yellow Fever, Adenovirus (often cause mild or subclinical hepatitis)

  • Non-Viral Causes:

    • Bacterial infections: Toxoplasma, Q fever, Rocky Mountain spotted fever

    • Parasitic infections (e.g., amebiasis)

  • Other Causes:

    • Alcohol (acute alcoholic hepatitis)

    • Toxins (e.g., industrial chemicals)

    • Drugs (e.g., certain antibiotics like amoxicillin, anti-tuberculosis medications like isoniazid, antiepileptics, minocycline)

    • Ischemic (due to circulatory insufficiency, leading to reduced blood flow to the liver)

    • Pregnancy-related issues (e.g., preeclampsia, HELLP syndrome)

    • Autoimmune (e.g., Systemic Lupus Erythematosus - SLE, often a broader systemic disease affecting the liver)

    • Metabolic (e.g., Wilson's disease - an inherited disorder that causes excess copper to accumulate in the liver and other organs, leading to liver damage)

Chronic Hepatitis ā€“ Causes

  • Autoimmune: Hepatitis due to the body's immune system mistakenly attacking its own liver cells, leading to ongoing inflammation and damage.

  • Alcoholic and Non-Alcoholic Fatty Liver Disease: Includes Alcoholic Steatohepatitis (ASH) and Non-Alcoholic Steatohepatitis (NASH), where fat accumulation in the liver leads to inflammation and injury, potentially progressing to fibrosis and cirrhosis.

  • Drug Related: Chronic liver damage resulting from long-term use or idiosyncratic reactions to certain medications, including methyldopa, isoniazid, ketoconazole, nitrofurantoin.

  • Hereditary Factors: Such as hemochromatosis (iron overload) or alpha-1 antitrypsin deficiency. Chronic HBV infection (with or without HDV co-infection) and HCV infection are also common causes of chronic viral hepatitis.

  • Viral ā€“ Hep B w/wo Hep D, Hep C

  • Hep D ā€“ only along with Hep B; NEEDS Hep B virus to replicate; not common in U.S.

  • Hepatitis G (HGV/GBV-C): While rare as a primary cause of severe liver disease, it sometimes presents in conjunction with chronic Hep B and C infections, though its contribution to liver pathology is generally considered minor.

Hepatitis A (HAV)

Transmission and Epidemiology

  • Transmission routes: Primarily fecal-oral route, indicating ingestion of contaminated material.

    • Contaminated water, milk, and food (e.g., raw shellfish harvested from contaminated waters, unwashed fruits/vegetables)

    • Poor sanitation and hygiene practices (e.g., insufficient handwashing after using the restroom or before preparing food, unwashed utensils)

  • Incubation Period: Typically 2 to 6 weeks.

  • Infection Duration: Symptoms usually last 4-8 weeks, though recovery can be longer for individuals over 40 years old or those with underlying health conditions.

  • High-Risk Groups: Young adults (20-29), males who have sex with males, attendees of daycare/pre-schools, individuals in overcrowded areas, and travelers to endemic regions.

Risk Factors

Ā·Ā Ā Ā Ā Ā  Travel or work in areas with high Hepatitis A rates.

Ā·Ā Ā Ā Ā Ā  Sexually active - > in males who have sex with males

Ā·Ā Ā Ā Ā Ā  Injected or non-injected illegal drugs.

Ā·Ā Ā Ā Ā Ā  Work in area where you are exposed to the virus.

Ā·Ā Ā Ā Ā Ā  In need of frequent or multiple blood products.

Ā·Ā Ā Ā Ā Ā  Tainted food, poor hygiene, overcrowded regions at higher risk.

Symptoms and Diagnosis

  • Preicteric Stage Symptoms:

    • Anorexia

    • Vague symptoms like fatigue

    • Dark urine ā€“ occurs due to bilirubin excretion by the kidneys before jaundice becomes visible in the skin.

    • Nausea/vomiting, abdominal discomfort, diarrhea

    • Muscle pain (myalgia)

    • Itching (pruritus) ā€“ rise of bile salts to top of skin.

    • Low-grade fever

  • Diagnosis:

    • HAV antigens in stool

    • IGM antibodies in serum ā€“ acute stage

    • IGG antibodies in serum ā€“ indicates past infection and confers immunity, or immunity from vaccination.

    • Elevated ALT levels ā€“ (Alanine Aminotransferase) are indicative of liver cell damage/inflammation, often significantly elevated in acute hepatitis.

Treatment and Prevention

  • Treatment: No specific antiviral treatment for HAV; recovery is usually spontaneous and self-limiting.

    • Supportive care:

      • Adequate nutrition and rest to support liver healing, avoiding alcohol and hepatotoxic over-the-counter medications (e.g., acetaminophen) until liver function normalizes.

    • Immune globulin (IG):

      • Can be administered to close contacts (lives in home or sexual partner) within 2 weeks of exposure to provide temporary passive immunity and prevent or lessen the severity of infection.

  • Prevention:

    • HAV vaccine:

      • Highly effective

      • Administered as 2 doses for adults and 3 doses for children.

      • Recommended for high-risk groups and for routine childhood immunization.

    • Hygiene practices:

      • Especially diligent handwashing with soap and water after using the restroom and before handling food.

Complications

  • Most cases resolve within 1-2 months without long-term consequences.

  • Fulminant Hepatitis:

    • A rare but severe complication, leading to rapid and acute liver failure, often requiring emergency liver transplantation. It is most common in individuals with pre-existing chronic liver disease.

  • Atherosclerosis

Hepatitis B (HBV)

Transmission and Epidemiology

  • Transmission methods:

    • Perinatal (most common route globally, from mother to newborn at birth)

    • Sexual contact (anal, vaginal, oral sex)

    • Blood or other body fluid contact (e.g., needlestick injuries, sharing needles among IV drug users, unsterile medical procedures)

    • Contaminated blood products, needles, unsterile tattoo or piercing equipment.

  • Incubation Period: Approximately 90 days, ranging from 60 to 150 days.

  • Epidemiology:

    • Highest rates observed in ages 30-39, but incidence varies by region and risk factors.

    • High prevalence among healthcare workers, dialysis patients, and recipients of blood transfusions before modern screening methods.

    • Hep B is 50 to 100 times more infectious than HIV, highlighting its ease of transmission.

    • An available vaccine is 95% effective in preventing infection.

Risk Factors

  • High-risk sexual behavior (multiple partners, unprotected sex).

  • Close contacts of infected individuals.

  • History of injectable drug use

  • Frequent blood product exposure (e.g., hemophiliacs)

  • Organ transplants

  • Healthcare occupation with exposure to blood.

  • Mother-to-child transmission if the mother is chronically infected.

  • STIs ā€“ at greater risk

Symptoms

  • Symptoms resemble those of HAV but often have a more insidious onset and longer incubation period.

  • Some patients are asymptomatic.

  • Possible preicteric and icteric symptoms:

    • Jaundice

    • Liver tenderness (hepatomegaly)

    • Dark urine

    • Persistent fatigue

    • Nausea, abdominal pain

    • Low-grade fever

    • Loss of appetite

    • Chronic HBV is often asymptomatic until significant liver damage occurs.

Diagnosis

  • Utilize HBsAg (Hepatitis B surface antigen):

    • To diagnose acute or chronic HBV infection.

    • A positive HBsAg indicates active infection and the presence of the virus in the blood.

  • Elevation of liver function tests (ALT, AST):

    • To determine the extent of liver cell damage, which can help differentiate acute from chronic stages.

  • Identifying antibodies and antigens:

    • HBeAg (Hepatitis B 'e' antigen):

      • Indicates active viral replication and high infectivity.

    • Anti-HBc (antibody to Hepatitis B core antigen):

      • Appears early in infection (IgM anti-HBc in acute, IgG anti-HBc in past/chronic) and usually persists for life, indicating past or current infection.

    • Anti-HBs (antibody to Hepatitis B surface antigen):

      • Denotes recovery from infection and immunity, or successful vaccination.

Treatment and Prevention

  • Treatment for Acute Disease:

    • No specific antiviral treatment available for acute HBV

    • Focus on patient comfort, adequate hydration, and symptom management

  • Chronic Disease Treatment: Aims to suppress viral replication, prevent progression to cirrhosis, and reduce the risk of liver cancer.

    • Interferon: An immune modulator, administered via injections.

    • Antiviral agents: Oral medications such as Epivir (lamivudine), Hepsera (adefovir), Viread (tenofovir), and Baraclude (entecavir) are used to inhibit viral DNA polymerase.

  • Prevention:

    • Practice good hygiene

    • Avoid unprotected sexual contact and use barrier methods (condoms)

    • Implement rigorous blood donor screening

    • Vaccinate against Hep B

    • Adhere to needle precautions in healthcare and among drug users.

    • Hep B Immunoglobulin, if necessary.

Complications

  • Fulminant Hepatitis (rare but severe acute liver failure)

  • Cirrhosis (irreversible scarring of the liver)

  • Liver Cancer (Hepatocellular Carcinoma) are significant long-term complications of chronic HBV infection.

Hepatitis C (HCV)

Transmission and Epidemiology

  • Transmission: Primarily blood-to-blood contact.

    • Intravenous (IV) drug use (most common route globally)

    • Needlestick injuries in healthcare settings

    • Sexual contact (less efficient than HBV, but risk increases with multiple partners or other STIs)

    • Illicit IV or intra nasal drugs

    • Receiving hemodialysis

    • Perinatal transmission (mother to infant)

    • Contaminated transfusions or organ transplants before universal screening was implemented (now very rare)

      • Organ transplants before 1992

      • Receiving blood prior to 1992 or clotting factors prior to 1987

Ā 

  • Hep C is the most common reason for liver transplants.

  • Incubation Period: Ranges from 15 days to over 160 days, typically 6-7 weeks.

  • Epidemiology:

    • The WHO reports approximately 58 million people chronically infected with Hep C worldwide.

    • Increased risk for healthcare workers, current/former intravenous drug users, individuals with tattoos or piercings from unregulated establishments, and hemophiliacs or others who received blood products before 1992.

Risk Factors:

Ā·Ā Ā Ā Ā Ā  Health care workers

Ā·Ā Ā Ā Ā Ā  Drug abusers

Ā·Ā Ā Ā Ā Ā  Tattoos

Ā·Ā Ā Ā Ā Ā  Hemophiliac

Ā·Ā Ā Ā Ā Ā  Sexually promiscuous

Ā·Ā Ā Ā Ā Ā  Increased need for blood and blood products

Symptoms

  • Mostly asymptomatic for many years, often leading to delayed diagnosis until significant liver damage has occurred.

  • Preicteric Symptoms:

    • Mild flu-like symptoms, persistent fatigue, nausea, myalgia (muscle pain), upper right quadrant tenderness.

  • Icteric Symptoms:

    • When present, may include profound fatigue, lack of appetite, jaundice, low-grade fever, nausea/vomiting.

    • These are less common than in HAV or HBV.

Diagnosis

  • Assess medical history (risk factors for exposure) and Anti-HCV antibodies levels.

  • Antibodies are detectable in 80% of infected individuals within 15 weeks, 90% within 5 months, and 97% within 6 months.

    • If antibodies are positive, an HCV RNA test (viral load) is needed to confirm active infection, as antibodies only indicate exposure, not necessarily current infection.

  • Liver biopsy: Performed to assess the degree of inflammation, fibrosis (scarring), and steatosis within the liver.

  • Elevated liver function tests (ALT, AST) are common, but can fluctuate.

Treatment

  • Treatment may be unnecessary for some individuals (e.g., those with spontaneous viral clearance), but most require therapy to prevent chronic progression.

  • Historically, treatment involved Pegylated interferon alfa injections with antiviral ribavirin, but this regimen had significant side effects and lower cure rates.

    • Injection ā€“ weekly

    • Oral ā€“ BID

  • Current standard treatment:

    • Highly effective direct-acting antiviral (DAA) medications.

    • These oral medications target specific viral enzymes, leading to high cure rates (over 95%) with fewer side effects.

  • Treatment duration varies depending on viral genotype, viral load, and presence of cirrhosis, typically 8-12 weeks.

  • Liver transplant consideration for severe cases of end-stage liver disease due to HCV.

  • Milk thistle can help decrease symptoms if diagnosed with NASH

Prevention

  • Avoidance of illegal drug use (especially IV drugs)

  • Avoid body piercing and tattooing from unsterile sources

  • Avoid risky sexual behavior.

  • Hand washing

  • Thorough blood donor screening

Complications

  • Chronic liver disease

  • Progression to cirrhosis

  • Primary hepatocellular carcinoma (liver cancer)

  • HCV is one of the leading causes of liver transplantation worldwide.

Hepatitis D (HDV)

Overview

  • Unique, defective RNA virus that is dependent on the presence of Hepatitis B virus (HBV) for its replication and assembly.

  • It cannot cause infection on its own.

  • Co-infection (simultaneous infection with HBV and HDV) or superinfection (HDV infection in a chronic HBV carrier) often intensifies acute symptoms of Hep B and accelerates liver damage.

Transmission and Epidemiology

  • Transmission through percutaneous exposure:

    • IV drug users

    • Hemodialysis

    • Blood transfusions (before screening)

    • Sexual contact

  • Incubation Period: Typically 7 to 8 weeks.

  • Found worldwide; approximately 10-15 million infected individuals globally, with antibodies present in 20-40% of HBsAg carriers in certain regions (e.g., Southern Europe, Africa, parts of South America, Middle East).

Risk Factors:

Ā·Ā Ā Ā Ā Ā  Infection with Hep B and positive for HBsAg

Ā·Ā Ā Ā Ā Ā  Hemodialysis

Ā·Ā Ā Ā Ā Ā  Sexual contact of infected people

Ā·Ā Ā Ā Ā Ā  Infants born to mothers who are infected

Symptoms

  • Symptoms often mimic or exacerbate HBV symptoms.

  • Preicteric Symptoms:

    • Persistent fatigue, lethargy

    • Nausea, anorexia

  • Icteric Symptoms:

    • Jaundice

    • Dark urine

    • Clay-colored stools

    • Elevated bilirubin levels

    • Are all common and often more severe than in HBV mono-infection.

Diagnosis and Treatment

  • Diagnosis:

    • Positive HBsAg (due to dependency on HBV)

    • Detection of HDV RNA (indicating active viral replication)

    • HDAg (Hepatitis D antigen)

    • IgM anti-HD antibodies (indicative of acute HDV infection or a flare-up of chronic infection).

  • Treatment:

    • No specific antiviral treatment available for HDV that directly targets the virus.

    • Treatment primarily focuses on managing the HBV infection.

  • Prevention:

    • Prevention of HDV mimics Hep B precautions, and HBV vaccination prevents HDV infection.

Complications

  • Fulminant Hepatitis (especially with co-infection)

  • Chronic Liver Disease that progresses more rapidly to cirrhosis and liver failure compared to HBV infection alone.

Hepatitis E (HEV)

Overview

  • A waterborne virus (oral-fecal)

  • Prevalent in areas with poor sanitation and contaminated water supplies.

    • Sewage has contaminated the water supply.

    • Can be transmitted through eating wild boar or uncooked deer meat.

  • Usually causes an acute, self-limiting infection.

Transmission

  • Transmitted primarily through:

    • Contaminated drinking water sources

    • Inadequate sewage systems

    • Consumption of undercooked meat (especially pork, wild boar, or deer meat)

Symptoms and Impact

  • Generally self-limiting and resolves on its own, but acute illness can be severe, causing symptoms that impair the ability to work for several weeks.

  • Jaundice is present in most symptomatic cases.

  • High risk for travelers to undeveloped countries where sanitation is poor.

  • It can be particularly dangerous for pregnant women, leading to a high mortality rate.

Hepatitis G (HGV)

Overview

  • Also known as GBV-C.

  • Little is known about its specific clinical significance.

  • Mostly associated with blood transfusions and IV drug use, often as a co-infection.

    • Hemophiliacs

    • Other conditions where large amounts of blood are transfused (Sickle Cell Anemia)

  • Infection might occur with other Hepatitis infections.

Nursing and Patient Education for Hepatitis

Key Education Points

  • Rest:

    • Emphasize importance of rest if LFTs are elevated.

    • Limiting physical activity helps conserve energy and allows the liver to heal.

  • Avoidance of Alcohol:

    • Crucial as alcohol is a hepatotoxin that can further damage an inflamed liver and impede recovery.

  • Do not share a bathroom with other people.

  • Dietary Modifications:

    • Employ small, frequent meals to reduce the burden on the liver and alleviate nausea.

    • A high carbohydrate and low-fat diet is often recommended to provide energy and minimize the need for the liver to process fats.

  • Medication Avoidance:

    • Avoid over-the-counter medications (especially acetaminophen) and herbal supplements unless cleared by a healthcare provider, due to potential hepatotoxicity.

  • Prevention of Spread:

    • Refrain from donating blood or blood products permanently (for HBV/HCV) and practice safe sexual activity and personal hygiene (handwashing) to prevent transmission.

Non-Viral Hepatitis (Toxic Hepatitis)

Potential Causes

  • Chemicals:

    • Toxic hepatitis caused by exposure to substances like phosphorus, chloroform, carbon tetrachloride, gold compounds, and certain industrial solvents.

    • Recovery is quicker if the toxic agent is identified and removed early, preventing further liver damage.

  • Medications:

    • Including acetaminophen (especially in overdose or chronic high doses), isoniazid (TB medication), certain antibiotics (e.g., amoxicillin/clavulanate, erythromycin), and some anesthetics (e.g., halothane).

  • Symptoms may subside after stopping the offending medication, but severe outcomes and risk of fatality are high in cases of long-term exposure or acute severe reactions, as these agents can cause direct hepatotoxicity or idiosyncratic immune-mediated liver injury.